FDA taps biotech veteran George Tidmarsh to lead drug center

Taking stock of the drug industry, from the lab to the medicine chest

July 21, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Sarah Silbiger/Getty Images STAT+ | New head of FDA drug center is a biotech veteran and an outspoken critic of the academic establishment Tidmarsh has worked for a number of biotechs and joins the FDA as the agency grapples with the effects of staff layoffs and departures. By Andrew Joseph and Jonathan Wosen STAT+ | Alkermes drug helped narcolepsy patients stay awake in Phase 2 trial The company says the results suggest the treatment, called alixorexton, could also help improve fatigue and cognition. By Elaine Chen STAT+ | Biotech VC Omega Funds raises $647 million fund The firm is an exception in an industry that has raised few fresh pools of capital so far this year. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser